Pharmacovigilance Outsourcing Global Market Report 2024

Description

Pharmacovigilance outsourcing involves hiring external service providers to manage and perform pharmacovigilance activities for pharmaceutical companies. These activities encompass detecting, assessing, understanding, and preventing adverse effects or other drug-related issues.

The primary types of pharmacovigilance outsourcing include adverse drug reaction capture (ADR), case processing, reporting and submission, report publishing, quality checks, risk management, knowledge management, and enabling architecture. ADR capture involves identifying, documenting, and analyzing harmful or unintended reactions to medications to ensure drug safety and enhance patient care. These services are typically offered by contract research organizations and business process outsourcing companies. The main users of these outsourced services include the pharmaceutical industry, research organizations, and other stakeholders.

The pharmacovigilance outsourcing market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance outsourcing market statistics, including pharmacovigilance outsourcing industry global market size, regional shares, competitors with a pharmacovigilance outsourcing market share, detailed pharmacovigilance outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance outsourcing industry. This pharmacovigilance outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacovigilance outsourcing market size has grown rapidly in recent years. It will grow from $5.25 billion in 2023 to $6.16 billion in 2024 at a compound annual growth rate (CAGR) of 17.3%. The growth during the historic period can be attributed to the rise in drug development activities, stringent regulatory requirements, a higher incidence of adverse drug reactions, growing concerns about patient safety, and an increase in outsourcing by small and mid-sized companies.

The pharmacovigilance outsourcing market size is expected to see rapid growth in the next few years. It will grow to $11.71 billion in 2028 at a compound annual growth rate (CAGR) of 17.4%. The growth projected for the forecast period can be attributed to the expansion of biologics and biosimilars, a heightened focus on personalized medicine, a growing demand for real-world evidence, the increasing complexity of drug safety profiles, and a stronger emphasis on patient-centric care. Key trends expected in this period include the increased use of big data analytics, a rise in partnerships and collaborations, the adoption of cloud-based pharmacovigilance solutions, the integration of pharmacovigilance with digital health platforms, and the development of specialized pharmacovigilance services for gene therapies.

The growth of the pharmacovigilance outsourcing market is anticipated to be driven by the increasing number of clinical trials. Clinical trials are research studies designed to assess the safety, effectiveness, and potential side effects of new treatments, drugs, or medical devices. The rise in clinical trials is fueled by factors such as the emphasis on precision medicine, the growing prevalence of chronic diseases, regulatory support, and the globalization of research. Outsourcing pharmacovigilance in clinical trials improves drug safety monitoring by utilizing specialized expertise and resources to ensure regulatory compliance and enhance efficiency. For instance, in November 2023, the Association of the British Pharmaceutical Industry reported a slight increase of 4.3% in the number of industry-sponsored clinical trials in the UK, rising from 394 in 2021 to 411 in 2022. Thus, the growing number of clinical trials is driving the expansion of the pharmacovigilance outsourcing market.

Key players in the pharmacovigilance outsourcing market are focusing on developing innovative solutions, such as cloud-based data lake platforms, to optimize pharmacovigilance case processing and safety data management. These platforms help enhance clinical research registries and ensure regulatory compliance. A cloud-based data lake platform is a centralized repository that stores and manages large volumes of raw data in its native format until needed. For example, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology and laboratory equipment company, introduced CorEvidence. This platform is designed to improve clinical research registries by streamlining pharmacovigilance case processing and managing multiple data sources. It optimizes the coding, classification, and reporting of adverse events, offering scalable, compliant, and auditable safety management while supporting long-term post-authorization safety studies across various therapeutic areas.

In November 2023, Permira Advisers LLP, a UK-based investment firm, acquired Ergomed PLC for $0.904 billion. This acquisition is intended to support Ergomed's growth by leveraging Permira's expertise, capital, and global network to enhance Ergomed's commercial, technological, and geographic capabilities and facilitate strategic acquisitions in the contract research organization (CRO) and pharmacovigilance (PV) sectors. Ergomed PLC, based in the UK, offers drug development services, including pharmacovigilance.

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Global Pharma Tek, Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

North America was the largest region in the pharmacovigilance outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacovigilance outsourcing market includes revenues earned by entities by providing services such as pharmacovigilance database management, assessment services, medical information call center services, regulatory consulting and strategy services, pharmacovigilance compliance and auditing, and aggregate reporting and benefit-risk evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance Outsourcing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Adverse Drug Reaction Capture (ADR); Case Processing; Reporting And Submission; Report Publishing; Quality Check; Risk Management; Knowledge Management; Enabling Architecture
2) By Service Provider: Contract Research Organization; Business Processing Outsourcing
3) By End User: Pharmaceutical Industry; Research Organization; Others End Users
Companies Mentioned: ACCENTURE PLC; International Business Machines Corporation (IBM); Tata Consultancy Services; Capgemini SE; Cognizant Technology Solutions Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20806

1. Executive Summary

2. Pharmacovigilance Outsourcing Market Characteristics

3. Pharmacovigilance Outsourcing Market Trends And Strategies

4. Pharmacovigilance Outsourcing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Pharmacovigilance Outsourcing Market Size and Growth

5.1. Global Pharmacovigilance Outsourcing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pharmacovigilance Outsourcing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pharmacovigilance Outsourcing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmacovigilance Outsourcing Market Segmentation

6.1. Global Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adverse Drug Reaction Capture (ADR)
Case Processing
Reporting And Submission
Report Publishing
Quality Check
Risk Management
Knowledge Management
Enabling Architecture
6.2. Global Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Contract Research Organization
Business Processing Outsourcing
6.3. Global Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical Industry
Research Organization
Others End Users

7. Pharmacovigilance Outsourcing Market Regional And Country Analysis

7.1. Global Pharmacovigilance Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pharmacovigilance Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmacovigilance Outsourcing Market

8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmacovigilance Outsourcing Market

9.1. China Pharmacovigilance Outsourcing Market Overview
9.2. China Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmacovigilance Outsourcing Market

10.1. India Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmacovigilance Outsourcing Market

11.1. Japan Pharmacovigilance Outsourcing Market Overview
11.2. Japan Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmacovigilance Outsourcing Market

12.1. Australia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmacovigilance Outsourcing Market

13.1. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmacovigilance Outsourcing Market

14.1. South Korea Pharmacovigilance Outsourcing Market Overview
14.2. South Korea Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmacovigilance Outsourcing Market

15.1. Western Europe Pharmacovigilance Outsourcing Market Overview
15.2. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmacovigilance Outsourcing Market

16.1. UK Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmacovigilance Outsourcing Market

17.1. Germany Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmacovigilance Outsourcing Market

18.1. France Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmacovigilance Outsourcing Market

19.1. Italy Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmacovigilance Outsourcing Market

20.1. Spain Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmacovigilance Outsourcing Market

21.1. Eastern Europe Pharmacovigilance Outsourcing Market Overview
21.2. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmacovigilance Outsourcing Market

22.1. Russia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmacovigilance Outsourcing Market

23.1. North America Pharmacovigilance Outsourcing Market Overview
23.2. North America Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmacovigilance Outsourcing Market

24.1. USA Pharmacovigilance Outsourcing Market Overview
24.2. USA Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmacovigilance Outsourcing Market

25.1. Canada Pharmacovigilance Outsourcing Market Overview
25.2. Canada Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmacovigilance Outsourcing Market

26.1. South America Pharmacovigilance Outsourcing Market Overview
26.2. South America Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmacovigilance Outsourcing Market

27.1. Brazil Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmacovigilance Outsourcing Market

28.1. Middle East Pharmacovigilance Outsourcing Market Overview
28.2. Middle East Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmacovigilance Outsourcing Market

29.1. Africa Pharmacovigilance Outsourcing Market Overview
29.2. Africa Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmacovigilance Outsourcing Market Competitive Landscape And Company Profiles

30.1. Pharmacovigilance Outsourcing Market Competitive Landscape
30.2. Pharmacovigilance Outsourcing Market Company Profiles
- 30.2.1. ACCENTURE PLC
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. International Business Machines Corporation (IBM)
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Tata Consultancy Services
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Capgemini SE
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Cognizant Technology Solutions Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Pharmacovigilance Outsourcing Market Other Major And Innovative Companies

31.1. IQVIA Holdings Inc.
31.2. Laboratory Corporation of America Holdings (Labcorp)
31.3. Wipro Limited
31.4. ICON PLC
31.5. Syneos Health
31.6. Genpact limited
31.7. Parexel International Corp
31.8. Veeva Systems Inc.
31.9. Medpace Holdings Inc.
31.10. ProPharma Group
31.11. Pharmalex GmbH
31.12. PrimeVigilance Ltd.
31.13. Global Pharma Tek
31.14. Veristat LLC
31.15. United BioSource LLC

32. Global Pharmacovigilance Outsourcing Market Competitive Benchmarking

33. Global Pharmacovigilance Outsourcing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmacovigilance Outsourcing Market

35. Pharmacovigilance Outsourcing Market Future Outlook and Potential Analysis

35.1 Pharmacovigilance Outsourcing Market In 2028 - Countries Offering Most New Opportunities
35.2 Pharmacovigilance Outsourcing Market In 2028 - Segments Offering Most New Opportunities
35.3 Pharmacovigilance Outsourcing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer